ALDER BIOPHARMACEUTICALS INC — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/63f2b791-a4c7-4c25-b8ed-fd7f84b97256/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-296.4M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004084 |
| FY 2017 | $-288.9M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-003221 |
| FY 2016 | $-156.3M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-002198 |
| FY 2015 | $-85.5M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013074 |
| FY 2014 | $8.9M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001662 |
| FY 2013 | $-20.6M | 2013-01-01 – 2013-12-31 | evidence 0001564590-15-001662 |
| FY 2012 | $-17.8M | 2012-01-01 – 2012-12-31 | evidence 0001564590-15-001662 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ALDER BIOPHARMACEUTICALS INC — all facts · Revenue · Operating Income